Detalhe da pesquisa
1.
Bispecific dendritic-T cell engager potentiates anti-tumor immunity.
Cell
; 187(2): 375-389.e18, 2024 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38242085
2.
LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma.
Cell
; 185(8): 1373-1388.e20, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35381199
3.
Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols.
Nat Cancer
; 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38429414
4.
In Synergy: Optimizing CAR T Development and Personalizing Patient Care Using Single-Cell Technologies.
Cancer Discov
; 13(7): 1546-1555, 2023 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37219074
5.
The transcriptional and regulatory identity of erythropoietin producing cells.
Nat Med
; 29(5): 1191-1200, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37106166
6.
Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling.
Nat Cancer
; 3(11): 1336-1350, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36302895
7.
The interaction of CD4+ helper T cells with dendritic cells shapes the tumor microenvironment and immune checkpoint blockade response.
Nat Cancer
; 3(3): 303-317, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35241835
8.
XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis.
Nat Med
; 27(6): 1043-1054, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34017133
9.
Author Correction: Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling.
Nat Cancer
; 3(11): 1404, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36376510
10.
Publisher Correction: XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis.
Nat Med
; 28(1): 214, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35022579